Company / Operating Cash Flow per Share
CAPRICOR THERAPEUTICS, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.22
FY2025
5-year range
-$1.22 / $0.19
FY2021-FY2025
Trend
-38.7%
vs FY2024
Sector context
#122 of 212
Health Care
What the data says
At $-1.22, CAPRICOR THERAPEUTICS, INC.'s operating cash flow per share ranks #122 of 212 in the Health Care sector. Operating Cash Flow per Share has declined for 3 consecutive years, from $0.19 in FY2022 to $-1.22 in FY2025.
Based on SEC 10-K filings.
-1.22 in FY2025.
Declined from $-0.82 to $-1.22 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 212 in Health CareTop 58% of 212This company -$1.22 Sector average -$14.69
▼
+91.7% above sector average
Key checks
Key Insights
- CAPRICOR THERAPEUTICS, INC.'s operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 38.7% year-over-year.
- Ranks #122 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.22 | -38.7% |
| FY2024 | -$0.88 | -6.8% |
| FY2023 | -$0.82 | -521.9% |
| FY2022 | $0.19 | +128.0% |
| FY2021 | -$0.70 | -42.2% |
| FY2020 | -$0.49 | +88.9% |
| FY2019 | -$4.42 | -900.0% |
| FY2018 | -$0.44 | +18.5% |
| FY2017 | -$0.54 | +19.8% |
| FY2016 | -$0.68 | -1.5% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026